Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Instagram Outage Disrupts Thousands of U.S. Users 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
SAN JUAN, Puerto Rico, Sept. 06, 2017 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) through its wholly-owned subsidiary, Project 1493 LLC, announced today that it has commenced construction on its third of five planned medical cannabis dispensary locations in Puerto Rico.
Situated in the centrally-located Puerto Nuevo neighborhood of San Juan, this location is one of four for which the Company has received pre-qualification for a dispensary license from the Department of Health of Puerto Rico (Green Spirit Completes Acquisition of Four Pre-Qualified Medical Marijuana Dispensary Applications). The Company anticipates construction to be completed at its San Juan location before the end of the year.
As previously announced, Green Spirit has submitted its application to obtain pre-qualification for a dispensary license at its fifth location in Puerto Rico (Green Spirit Signs Lease and Submits Application). Once construction at each location is completed and passes inspection by the Department of Health of Puerto Rico, the requisite operating permit is issued.
“The fourth quarter of 2017 is looking to be momentous for Green Spirit, with three dispensaries currently under construction and projected to open before the end of the year,” said Les Ball, CEO of Green Spirit. “With our plans for additional locations well underway, we intend to quickly establish Green Spirit as the preferred dispensary for medical cannabis patients throughout the island. Our locations will be clean, safe and reputable dispensaries to serve Puerto Rico’s patients, as well as tourists/visitors to the island who have been issued medical cannabis recommendations within their home state, with the high-quality medical cannabis products they seek.”
About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), together with its wholly-owned subsidiary, Project 1493, LLC, is in the business of acquiring, developing and operating medical marijuana dispensaries.
Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.
Contact: Paul Gendreau PGPR [email protected] 678-807-7945
